The miR-502 binding site SNP rs16917496 in the 3′UTR of SET8, first identified by Yu et al. [21], has been reported to contribute to susceptibility of breast cancer and ovarian cancer [35], [36], and clinical outcome of small cell lung cancer and hepatocellular carcinoma [37], [49]. Here, KMT5A is linked to breast carcinoma.